# Schrödinger

Type: Company (SDGR)

Source: GetYourBrief — https://getyourbrief.com/entity/schrdinger
Canonical HTML page: https://getyourbrief.com/entity/schrdinger

## Recent coverage (3 stories, network-wide)

### AI-Driven Verticals: Schrödinger and GoodRx 2025 Results Signal Sector Maturity
2026-02-26 03:32:19 · Sector: ai · Sentiment: Neutral · Impact: 5/10 · Sources: 3

Schrödinger and GoodRx reported full-year 2025 results, demonstrating the growing financial impact of AI-driven computational platforms in drug discovery and healthcare. These reports, alongside Churchill Downs' record performance, highlight a broader trend of data-centric companies leveraging machine learning to optimize specialized market verticals.
Full story: https://getaibrief.com/story/schrodinger-goodrx-churchill-downs-2025-earnings-analysis

### GoodRx and Schrödinger Report 2025 Results Amid Shifting Pharma Tech Landscape
2026-02-26 03:31:42 · Sector: bio · Sentiment: Neutral · Impact: 5/10 · Sources: 3

GoodRx and Schrödinger released their full-year 2025 financial results, highlighting a critical period of transition for digital health and computational drug discovery. While GoodRx focused on stabilizing its prescription marketplace margins, Schrödinger demonstrated the growing scalability of its AI-driven software platform alongside its internal clinical pipeline.
Full story: https://getbiobrief.com/story/goodrx-schrodinger-2025-earnings-analysis

### Health IT Earnings: GoodRx Beats Estimates as Schrödinger Targets ACV Growth
2026-02-26 03:27:18 · Sector: health · Sentiment: Neutral · Impact: 5/10 · Sources: 3

GoodRx reported Q4 2025 sales that exceeded market expectations, yet shares fell nearly 12% as investors weighed future guidance and margin pressures. Meanwhile, Schrödinger is pivoting toward a hosted platform model, targeting 10-15% growth in annual contract value for its computational drug discovery suite.
Full story: https://gethealthbrief.com/story/goodrx-schrodinger-q4-2025-earnings-analysis

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.